Evidence map›Paper›PMID 26370315›Full record

ArticleJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology2015

Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancy.

Samantha E Jacobs, Daryl M Lamson, Rosemary Soave, Brigitte Huertas Guzman, Tsiporah B Shore, Ellen K Ritchie, Dana Zappetti, Michael J Satlin, John P Leonard, Koen van Besien and 4 more

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Article
  10. Review
  11. Article
  12. Viral Respiratory Infections in Hematological Patients.Infectious diseases and therapy · 2020
    Review
  13. Observational
  14. Review
  15. Human Rhinovirus Infections in Hematopoietic Cell Transplant Recipients: Risk Score for Progression to Lower Respiratory Tract Infection.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2019
    Article
  16. Article
  17. Transmission and Control of Respiratory Viral Infections in the Healthcare Setting.Current treatment options in infectious diseases · 2018
    Review
  18. Severe Respiratory Viral Infections: New Evidence and Changing Paradigms.Infectious disease clinics of North America · 2017
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Samantha E JacobsDivision of Infectious Diseases, Weill Cornell Medical Center, New York, NY, USA. Electronic address: sej9006@med.cornell.edu.
Daryl M LamsonVirology Laboratory, Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Rosemary SoaveDivision of Infectious Diseases, Weill Cornell Medical Center, New York, NY, USA.
Brigitte Huertas GuzmanDivision of Infectious Diseases, Weill Cornell Medical Center, New York, NY, USA.
Tsiporah B ShoreDivision of Hematology and Medical Oncology, Weill Cornell Medical Center, New York, NY, USA.
Ellen K RitchieDivision of Hematology and Medical Oncology, Weill Cornell Medical Center, New York, NY, USA.
Dana ZappettiDivision of Pulmonary and Critical Care Medicine, New York Presbyterian Hospital/ Weill Cornell Medical College, New York, NY, USA.
Michael J SatlinDivision of Infectious Diseases, Weill Cornell Medical Center, New York, NY, USA.
John P LeonardDivision of Hematology and Medical Oncology, Weill Cornell Medical Center, New York, NY, USA.
Koen van BesienDivision of Hematology and Medical Oncology, Weill Cornell Medical Center, New York, NY, USA.
Audrey N SchuetzDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical Center, New York, NY, USA.
Stephen G JenkinsDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical Center, New York, NY, USA.
Kirsten St GeorgeVirology Laboratory, Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Thomas J WalshDivision of Infectious Diseases, Weill Cornell Medical Center, New York, NY, USA.
Cornell University · USNew York Hospital Queens · USNew York State Department of Health · USWadsworth Center · US

Funding

Clinical and Translational Science CenterUL1TR000457 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2012 to 2016
$46.0M
T32: Pathogenesis of Infectious Diseases Training ProgramT32AI007613 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI ROY M. GULICK · 1999 to 2026
$8.8M
NCATS NIH HHS UL1 TR000457NCATS NIH HHS UL1TR000457
6 · The paper itself

Abstract

backgroundHuman rhinoviruses (HRVs) are common causes of upper respiratory tract infection (URTI) in hematologic malignancy (HM) patients. Predictors of lower respiratory tract infection (LRTI) including the impact of HRV species and types are poorly understood.

objectivesThis study aims to describe the clinical and molecular epidemiology of HRV infections among HM patients. STUDY

designFrom April 2012-March 2013, HRV-positive respiratory specimens from symptomatic HM patients were molecularly characterized by analysis of partial viral protein 1 (VP1) or VP4 gene sequence. HRV LRTI risk-factors and outcomes were analyzed using multivariable logistic regression.

resultsOne hundred and ten HM patients presented with HRV URTI (n=78) and HRV LRTI (n=32). Hypoalbuminemia (OR 3.0; 95% CI, 1.0-9.2; p=0.05) was independently associated with LRTI, but other clinical and laboratory markers of host immunity did not differ between patients with URTI versus LRTI. Detection of bacterial co-pathogens was common in LRTI cases (25%). Among 92 typeable respiratory specimens, there were 58 (64%) HRV-As, 12 (13%) HRV-Bs, and 21 (23%) HRV-Cs, and one Enterovirus 68. LRTI rates among HRV-A (29%), HRV-B (17%), and HRV-C (29%) were similar. HRV-A infections occurred year-round while HRV-B and HRV-C infections clustered in the late fall and winter.

conclusionsHRVs are associated with LRTI in HM patients. Illness severity is not attributable to specific HRV species or types. The frequent detection of bacterial co-pathogens in HRV LRTIs further substantiates the hypothesis that HRVs predispose to bacterial superinfection of the lower airways, similar to that of other community-acquired respiratory viruses.

Indexed as

AdolescentAdultAgedAged, 80 and overCluster AnalysisFemaleHematologic NeoplasmsHumansMaleMiddle AgedMolecular EpidemiologyPhylogenyPicornaviridae InfectionsRespiratory Tract InfectionsRhinovirusSequence Analysis, DNAViral Structural ProteinsHematologic malignancyHuman rhinovirusImmunocompromised hostsRhinovirus speciesViral pneumonia

Identifiers

PMID26370315
PMCPMC4750469
OpenAlexW2142310966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.